Investigators present phase II data for CBT-001 for the treatment of pterygia May 13, 2019 No Comments
OliX expands ocular disease pipeline with new OLX-304A program in retinitis pigmentosa May 13, 2019 No Comments
Nintedanib ophthalmic nanosuspension tested in animal model as pterygium treatment May 10, 2019 No Comments
Oyster Point studies long-term safety of OC-01 nasal spray in ONSET extension trial May 9, 2019 No Comments
Allakos reports promising data from phase I study of AK-002 in severe allergic conjunctivitis May 8, 2019 No Comments
Phase II trial of Nepafenac Evolute shows postoperative pain reduction after cataract surgery May 8, 2019 No Comments
First-in-human data presented for IVMED-10 and IVMED-20 for post-cataract inflammation May 8, 2019 No Comments
Ocular Therapeutix presents preliminary first-in-human data for OTX-TIC implant May 8, 2019 No Comments
RSS